GBTGuerbet SA
7.890EUR+1.15%Mkt Cap: 107.73M $P/E:

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…

Key Statistics

Company
Market Cap107.73M $
Enterprise Value452.77M $
Revenue (TTM)868.12M $
Gross Profit615.42M $
Net Income (TTM)-117.75M $
Revenue/Share68.82 USD
Last Price7.890 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.7K
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)6.31
PEG0.07
EV/EBITDA9.06
EV/Revenue0.52
P/S0.12
P/B0.37
EPS (TTM)-8.91
EPS (Forward)1.23
52W Range
7.4303% of range21.80
52W High21.80 EUR
52W Low7.430 EUR
Profitability
Gross Margin70.89%
Oper. Margin-1.70%
EBITDA Margin5.76%
Profit Margin-13.56%
ROE-40.57%
ROA-11.65%
Growth
Revenue Growth-5.20%
Earnings Growth
Cash Flow & Leverage
Operating CF88.14M $
CapEx (TTM)39.79M $
FCF Margin9.29%
FCF Yield74.89%
Net Debt354.02M $
Net Debt/EBITDA7.08
Balance Sheet
Debt/Equity1.65
Current Ratio2.49
Quick Ratio1.08
Book Value/Sh21.16 EUR
Cash/Share9.158 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield2.65%
Payout Ratio0.00%
Ex-Div DateJul 1, 2024
Pay Date
Splits
Last Split4:1
Split DateJan 23, 2014
Analyst Consensus
Rating
Target (Mean)8.433 EUR
Upside (mean)+6.9%
Target Range8.000 EUR9.000 EUR
8.000+6.9% to mean9.000
# Analysts3
Ownership
Shares Out.12.55M
Float5.26M
Insiders63.21%
Institutions5.47%
Technical
SMA 508.683 (-9.1%)
SMA 20011.55 (-31.7%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)11.89K
Avg Vol (10d)7.79K
Technical Indicators
RSI (14)35.3
MACD-0.2091
MACD Signal-0.2305
MACD Hist.+0.0214
BB Upper8.407 EUR
BB Middle7.992 EUR
BB Lower7.578 EUR
BB Width10.38%
ATR (14)0.2294 EUR
Vol Ratio (20d)0.47x